姑息放疗后疗效评估缺失:可评估但未评估(EBNE)事件的回顾性研究
该研究回顾性分析了2018年9月至2019年3月间309例姑息放疗事件,发现64.4%有放射肿瘤科医生撰写的记录,24.0%的可评估事件(63/262)虽存活超过60天且继续随访,但16周内无放射肿瘤科医生记录,被定义为EBNE。EBNE框架有助于区分记录缺失与临床不可评估。
要点
- 309例姑息放疗事件中,仅64.4%有放射肿瘤科医生撰写的评估记录。
- 可评估事件中24.0%为EBNE,即存活>60天但16周内无放疗科记录。
- EBNE发生于骨、脑等多种治疗部位,提示评估缺失普遍存在。
核心结论
- 相当比例的临床可评估姑息放疗事件缺乏放射肿瘤科医生撰写的记录。
- EBNE框架可区分基于记录的无评估与临床不可行,提高真实世界结局解读的透明度。
研究设计与样本
- 回顾性研究,纳入2018年9月至2019年3月间309例姑息放疗事件。
- 通过病历审查确定放疗后16周内是否有放射肿瘤科医生撰写的记录。
- 比较放射肿瘤科医生与非放射肿瘤科提供者的随访时长。
主要发现
- 309例事件(中位年龄64.5岁)中,199例(64.4%)有放射肿瘤科医生撰写的记录。
- 放射肿瘤科医生随访时长0-413天(中位75天),非放射肿瘤科提供者为0-418天(中位110.5天),log-rank P < .0001。
- 剩余262例可评估事件中,63例(占可评估24.0%,占总20.4%)为EBNE,即存活超过60天且继续机构随访但16周内无放疗科记录。
- EBNE发生于包括骨和脑在内的多个治疗部位。
关键数值与推荐
- 可评估但未评估(EBNE)定义为:存活超过60天且继续机构随访,但16周内无放射肿瘤科医生撰写的记录。
- 不可评估定义为:60天内死亡或失访。
临床怎么用
- 对姑息放疗患者应系统记录放疗后评估,减少EBNE事件。
- 在解读真实世界姑息放疗结局时,应区分记录缺失与临床不可评估。
局限性
- 回顾性研究设计,可能存在记录偏倚。
- 单中心数据,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Palliative radiation therapy (RT) is widely used for symptom control across diverse clinical settings. In routine practice, however, post-treatment evaluation may not be consistently documented. We examined real-world patterns of response documentation after palliative RT and identified episodes that were clinically evaluable but not formally evaluated. METHODS AND MATERIALS: We retrospectively reviewed 309 treatment episodes of palliative RT delivered between September 2018 and March 2019. Clinical records were examined to determine whether radiation oncologist-authored documentation was present within 16 weeks after RT. Follow-up duration was compared between radiation oncologists and non- radiation oncology providers. Episodes were classified as evaluated, nonevaluable (death or loss to follow-up within 60 days), or evaluable but not evaluated (EBNE; survival beyond 60 days with continued institutional follow-up but no radiation oncologist-authored documentation within 16 weeks). RESULTS: Among 309 treatment episodes (median age, 64.5 years), radiation oncologist-authored documentation was observed in 199 episodes (64.4%). Follow-up duration ranged from 0 to 413 days (median, 75 days) for radiation oncologists and from 0 to 418 days (median, 110.5 days) for non-radiation oncology providers (log-rank P < .0001). Forty-seven episodes (15.2%) were classified as nonevaluable. Among the remaining 262 evaluable episodes, 63 (24.0% of evaluable; 20.4% of total) had no radiation oncologist-authored documentation within 16 weeks despite survival beyond 60 days and were categorized as EBNE. EBNE occurred across treatment sites, including bone and brain indications. CONCLUSIONS: A substantial proportion of clinically evaluable palliative RT episodes lacked radiation oncologist-authored documentation. The EBNE framework offers a reproducible method to separate documentation-based nonevaluation from clinical infeasibility, improving transparency in the interpretation of real-world palliative RT outcomes.
引用
- Tanaka H, Abe S, Wakabayashi K, et al. Unassessed Response After Palliative Radiotherapy: A Retrospective Study of Evaluable but Not Evaluated (EBNE) Episodes. Int J Radiat Oncol Biol Phys. 2026. PMID: 41999782. doi:10.1016/j.ijrobp.2026.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。